Antithrombin - A Prospective, MultiCenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Preoperative Antithrombin Supplementation in Patients Undergoing High-Risk Cardiac Surgery with Cardiopulmonary Bypass

Grants and Contracts Details

StatusFinished
Effective start/end date5/8/155/7/17

Funding

  • Grifols Worldwide Operations Limited: $14,517.00